Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of ...

The following is a summary of “Chronic hepatitis B virus infection increases the risk of kidney disease while antiviral ...

The agency has launched a whole genome sequencing service to monitor the virus The UK Health Security Agency (UKHSA) has announced the launch of a whole genome sequencing service to tackle hepatitis C ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting ...

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids.

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

An international team of researchers co-led by Job Dekker, Ph.D., at UMass Chan Medical School, have identified rules that tell cells how to fold DNA into the tightly packed, iconic X-shaped ...